ARCHIVES

Recombinant TSH Avoids Need To Stop Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

ECOG Phase III Trial To Test Hormones Vs. Chemotherapy For Prostate Cancer.

July 4, 2003

Minorities Increasingly Involved In Research, Training Programs

December 5, 1986

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

October 8, 2004

Court Orders NIH To Retract Electronic Annotations On Fisher Publications

March 24, 1995

Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds

October 2, 1992